Sun Of India Sued By U.K.'s AstraZeneca Over Nexium IV Generic
This article was originally published in PharmAsia News
Executive Summary
India's Sun Pharmaceuticals Industries has been sued by U.K.-based AstraZeneca to block Sun from marketing a generic of ulcer drug Nexium IV (esomeprazole) in the United States